Henrik Toft‐Hansen

1.2k total citations
24 papers, 965 citations indexed

About

Henrik Toft‐Hansen is a scholar working on Neurology, Immunology and Molecular Biology. According to data from OpenAlex, Henrik Toft‐Hansen has authored 24 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 11 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Henrik Toft‐Hansen's work include Neuroinflammation and Neurodegeneration Mechanisms (12 papers), Immune Response and Inflammation (5 papers) and Celiac Disease Research and Management (5 papers). Henrik Toft‐Hansen is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (12 papers), Immune Response and Inflammation (5 papers) and Celiac Disease Research and Management (5 papers). Henrik Toft‐Hansen collaborates with scholars based in Denmark, Canada and United States. Henrik Toft‐Hansen's co-authors include Trevor Owens, Alicia A. Babcock, Jason M. Millward, Bente Finsen, Helle Hvilsted Nielsen, Dylan R. Edwards, Robert K. Nuttall, Lasse Dissing‐Olesen, Reza Khorooshi and Thomas Hellesøe Holm and has published in prestigious journals such as Journal of Neuroscience, The Journal of Immunology and PLoS ONE.

In The Last Decade

Henrik Toft‐Hansen

23 papers receiving 955 citations

Peers

Henrik Toft‐Hansen
Ellie McCrea Canada
Ajaib S. Paintlia United States
Meng‐Liang Zhao United States
Joshua Norris United States
George Trendelenburg Germany
Katharina Borst Germany
Belinda J. Kaskow United States
Jeremy Seto United States
Shaun M. Sparacio United States
Brandi J. Baker United States
Ellie McCrea Canada
Henrik Toft‐Hansen
Citations per year, relative to Henrik Toft‐Hansen Henrik Toft‐Hansen (= 1×) peers Ellie McCrea

Countries citing papers authored by Henrik Toft‐Hansen

Since Specialization
Citations

This map shows the geographic impact of Henrik Toft‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Toft‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Toft‐Hansen more than expected).

Fields of papers citing papers by Henrik Toft‐Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Toft‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Toft‐Hansen. The network helps show where Henrik Toft‐Hansen may publish in the future.

Co-authorship network of co-authors of Henrik Toft‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Toft‐Hansen. A scholar is included among the top collaborators of Henrik Toft‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Toft‐Hansen. Henrik Toft‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toft‐Hansen, Henrik, Madeleine Dahlbäck, William Hagopian, et al.. (2025). Characterization of Anti-Insulin Antibodies in Type 1 and Type 2 Diabetes Mellitus: Clinical Relevance. International Journal of Molecular Sciences. 26(4). 1730–1730. 2 indexed citations
2.
Grimaldi, Christine, Susan Richards, Daniel Baltrukonis, et al.. (2025). IQ Survey Results on Current Industry Practices—Part 1: Immunogenicity Risk Assessment. Clinical Pharmacology & Therapeutics. 117(6). 1596–1604.
3.
Toft‐Hansen, Henrik, et al.. (2021). Calibration–free concentration analysis for quantification of anti-drug specific antibodies in polyclonal positive control antibodies and in clinical samples. Journal of Immunological Methods. 497. 113002–113002. 5 indexed citations
4.
Prajeeth, Chittappen Kandiyil, Reza Khorooshi, Benjamin Knier, et al.. (2017). Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties. Journal of Neuroinflammation. 14(1). 204–204. 96 indexed citations
5.
Nielsen, Christian, et al.. (2017). The composition of T cell subtypes in duodenal biopsies are altered in coeliac disease patients. PLoS ONE. 12(2). e0170270–e0170270. 18 indexed citations
6.
Lund, Flemming, Mette N. Hermansen, Merete Pedersen, et al.. (2015). Mapping of HLA– DQ haplotypes in a group of Danish patients with celiac disease. Scandinavian Journal of Clinical and Laboratory Investigation. 75(6). 519–522. 6 indexed citations
7.
8.
Cédile, Oriane, Morten Løbner, Henrik Toft‐Hansen, et al.. (2014). Thymic CCL2 influences induction of T-cell tolerance. Journal of Autoimmunity. 55. 73–85. 21 indexed citations
9.
Toft‐Hansen, Henrik, Erwin Roggen, Ludvig M. Sollid, et al.. (2013). Treatment of native or deamidated gluten peptides with an endo-peptidase from Aspergillus niger prevents stimulation of gluten-reactive T cells derived from children or adults with celiac disease. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
10.
Buist, Richard, Marc R. Del Bigio, Henrik Toft‐Hansen, et al.. (2012). Blood–brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation. Fluids and Barriers of the CNS. 9(1). 10–10. 27 indexed citations
11.
Nielsen, Helle Hvilsted, Henrik Toft‐Hansen, Kate Lykke Lambertsen, Trevor Owens, & Bente Finsen. (2011). Stimulation of Adult Oligodendrogenesis by Myelin-Specific T Cells. American Journal Of Pathology. 179(4). 2028–2041. 26 indexed citations
12.
13.
Holm, Thomas Hellesøe, et al.. (2010). Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system. Brain Behavior and Immunity. 25(5). 897–904. 46 indexed citations
14.
Nielsen, Helle Hvilsted, Rune Ladeby, Christina Fenger, et al.. (2009). Enhanced Microglial Clearance of Myelin Debris in T Cell-Infiltrated Central Nervous System. Journal of Neuropathology & Experimental Neurology. 68(8). 845–856. 27 indexed citations
15.
Toft‐Hansen, Henrik, Alicia A. Babcock, Jason M. Millward, & Trevor Owens. (2007). Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system. Journal of Neuroinflammation. 4(1). 24–24. 20 indexed citations
16.
Dissing‐Olesen, Lasse, Rune Ladeby, Helle Hvilsted Nielsen, et al.. (2007). Axonal lesion-induced microglial proliferation and microglial cluster formation in the mouse. Neuroscience. 149(1). 112–122. 55 indexed citations
17.
Toft‐Hansen, Henrik, et al.. (2006). Metalloproteinases Control Brain Inflammation Induced by Pertussis Toxin in Mice Overexpressing the Chemokine CCL2 in the Central Nervous System. The Journal of Immunology. 177(10). 7242–7249. 69 indexed citations
18.
Babcock, Alicia A., Martin Wirenfeldt, Thomas Hellesøe Holm, et al.. (2006). Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation. Journal of Neuroscience. 26(49). 12826–12837. 158 indexed citations
19.
Owens, Trevor, Alicia A. Babcock, Jason M. Millward, & Henrik Toft‐Hansen. (2005). Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Research Reviews. 48(2). 178–184. 95 indexed citations
20.
Toft‐Hansen, Henrik, Robert K. Nuttall, Dylan R. Edwards, & Trevor Owens. (2004). Key Metalloproteinases Are Expressed by Specific Cell Types in Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 173(8). 5209–5218. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellie McCrea Breakdown of academic impact, for papers by Ajaib S. Paintlia Breakdown of academic impact, for papers by Meng‐Liang Zhao Breakdown of academic impact, for papers by Joshua Norris Breakdown of academic impact, for papers by George Trendelenburg Breakdown of academic impact, for papers by Katharina Borst Breakdown of academic impact, for papers by Belinda J. Kaskow Breakdown of academic impact, for papers by Jeremy Seto Breakdown of academic impact, for papers by Shaun M. Sparacio Breakdown of academic impact, for papers by Brandi J. Baker
Rankless by CCL
2026